Literature DB >> 12171967

Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.

M D Crabtree1, I P M Tomlinson, S V Hodgson, K Neale, R K S Phillips, R S Houlston.   

Abstract

BACKGROUND: Familial adenomatous polyposis (FAP) is characterised by variable phenotypic expression. Part of this is attributable to a relationship between APC genotype and phenotype but there remains significant intrafamilial variation. In the Min mouse model of FAP, differences in the severity of gastrointestinal polyposis result from the action of modifier genes. AIMS: To determine whether phenotypic variation in human FAP has an inherited component consistent with the action of modifier genes.
METHOD: We systematically examined polyp numbers in colectomy specimens from patients with classical FAP. Variation both between and within families was analysed. Formal modelling of the segregation of disease severity in families was performed
RESULTS: There was strong evidence for a relationship between site of mutation and the number of colorectal polyps, with germline mutations in the "cluster region" causing the most severe disease and those with mutations between codons 1020 and 1169 having the mildest disease. In addition to this genotype-phenotype relationship, we found evidence for non-APC linked genetic modifiers of disease expression. First degree relatives had more similar polyp counts than more distant relatives. Formal modelling of the segregation of disease severity in families revealed further evidence for the action of modifier genes, with a best fit to a mixed model of inheritance.
CONCLUSION: Our data provide good evidence to support the hypothesis that modifier genes influence the severity of FAP in humans.

Entities:  

Mesh:

Year:  2002        PMID: 12171967      PMCID: PMC1773342          DOI: 10.1136/gut.51.3.420

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein.

Authors:  W Friedl; S Meuschel; R Caspari; C Lamberti; S Krieger; M Sengteller; P Propping
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Analysis of family resemblance. 3. Complex segregation of quantitative traits.

Authors:  N E Morton; C J MacLean
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

3.  Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC.

Authors:  W S Samowitz; A Thliveris; L N Spirio; R White
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

4.  Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation.

Authors:  F M Giardiello; A J Krush; G M Petersen; S V Booker; M Kerr; L L Tong; S R Hamilton
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

5.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

6.  Alleles of the APC gene: an attenuated form of familial polyposis.

Authors:  L Spirio; S Olschwang; J Groden; M Robertson; W Samowitz; G Joslyn; L Gelbert; A Thliveris; M Carlson; B Otterud
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis.

Authors:  K P Nugent; R K Phillips; S V Hodgson; S Cottrell; J Smith-Ravin; K Pack; W F Bodmer
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

8.  Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.

Authors:  G J Riggins; S Markowitz; J K Wilson; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36.

Authors:  I P Tomlinson; K Neale; I C Talbot; A D Spigelman; C B Williams; R K Phillips; W F Bodmer
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

10.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

View more
  24 in total

1.  K-ras mutation and loss of heterozygosity at 17p with beta-catenin accumulation in intramucosal carcinoma of the ileostomy in familial adenomatous polyposis: a case report.

Authors:  Keisuke Hata; Toshiaki Watanabe; Yutaka J Kawamura; Hironori Ishigami; Takamitsu Kanazawa; Tomohiro Tada; Bin Zhao; Shinichiro Koketsu; Hirokazu Nagawa
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

2.  Top down or bottom up? Competing management structures in the morphogenesis of colorectal neoplasms.

Authors:  N A Wright; R Poulsom
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

3.  Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.

Authors:  Jackie Haines; Victoria Johnson; Kevin Pack; Nirosha Suraweera; Predrag Slijepcevic; Erik Cabuy; Margaret Coster; Mohammad Ilyas; Jennifer Wilding; Oliver Sieber; Walter Bodmer; Ian Tomlinson; Andrew Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.

Authors:  Karla L Otterpohl; Karen A Gould
Journal:  Mamm Genome       Date:  2015-05-15       Impact factor: 2.957

5.  Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

Authors:  Nathalie Perreault; Sara D Sackett; Jonathan P Katz; Emma E Furth; Klaus H Kaestner
Journal:  Genes Dev       Date:  2005-01-13       Impact factor: 11.361

6.  Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.

Authors:  Krzysztof Flisikowski; Marek Switonski; Agata Sikorska; Tatiana Flisikowska; Monika Stachowiak; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2018-08-25       Impact factor: 3.240

7.  Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families.

Authors:  J M Chiang; H W Chen; R P Tang; J S Chen; C R Changchien; P S Hsieh; J Y Wang
Journal:  Fam Cancer       Date:  2009-09-19       Impact factor: 2.375

8.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors:  M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

9.  Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype.

Authors:  M L Bisgaard; R Ripa; A L Knudsen; S Bülow
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 10.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.